Syndax Pharmaceuticals Stock Technical Analysis
| SNDX Stock | USD 19.30 0.03 0.16% |
As of the 4th of June, Syndax Pharmaceuticals has the Coefficient Of Variation of (917.09), risk adjusted performance of (0.06), and Variance of 7.06. In relation to fundamental indicators, the technical analysis model makes it possible for you to check existing technical drivers of Syndax Pharmaceuticals, as well as the relationship between them. In other words, you can use this information to find out if the company will indeed mirror its model of past prices and volume data, or the prices will eventually revert. We were able to break down thirteen technical drivers for Syndax Pharmaceuticals, which can be compared to its competition. Please validate Syndax Pharmaceuticals market risk adjusted performance and treynor ratio to decide if Syndax Pharmaceuticals is priced more or less accurately, providing market reflects its prevalent price of 19.3 per share. Given that Syndax Pharmaceuticals has information ratio of (0.12), we advise you to double-check Syndax Pharmaceuticals's current market performance to make sure the company can sustain itself at a future point.
Syndax Pharmaceuticals Momentum Analysis
Momentum indicators are widely used technical indicators which help to measure the pace at which the price of specific equity, such as Syndax, fluctuates. Many momentum indicators also complement each other and can be helpful when the market is rising or falling as compared to SyndaxSyndax |
Syndax Pharmaceuticals Analyst Consensus
| Target Price | Advice | # of Analysts | |
| 36.09 | Strong Buy | 13 | Odds |
Most Syndax analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand Syndax stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of Syndax Pharmaceuticals, talking to its executives and customers, or listening to Syndax conference calls.
Syndax Pharmaceuticals technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Syndax Pharmaceuticals Technical Analysis
Incorrect Input. Please change your parameters or increase the time horizon required for running this function. The output start index for this execution was zero with a total number of output elements of zero. The Average True Range was developed by J. Welles Wilder in 1970s. It is one of components of the Welles Wilder Directional Movement indicators. The ATR is a measure of Syndax Pharmaceuticals volatility. High ATR values indicate high volatility, and low values indicate low volatility.
Syndax Pharmaceuticals Trend Analysis
Use this graph to draw trend lines for Syndax Pharmaceuticals. You can use it to identify possible trend reversals for Syndax Pharmaceuticals as well as other signals and approximate when it will take place. Remember, you need at least two touches of the trend line with actual Syndax Pharmaceuticals price movement. To start drawing, click on the pencil icon on top-right. To remove the trend, use eraser icon.Syndax Pharmaceuticals Best Fit Change Line
The following chart estimates an ordinary least squares regression model for Syndax Pharmaceuticals applied against its price change over selected period. The best fit line has a slop of 0.06 , which may suggest that Syndax Pharmaceuticals market price will keep on failing further. It has 122 observation points and a regression sum of squares at 130.54, which is the sum of squared deviations for the predicted Syndax Pharmaceuticals price change compared to its average price change.About Syndax Pharmaceuticals Technical Analysis
The technical analysis module can be used to analyzes prices, returns, volume, basic money flow, and other market information and help investors to determine the real value of Syndax Pharmaceuticals on a daily or weekly bases. We use both bottom-up as well as top-down valuation methodologies to arrive at the intrinsic value of Syndax Pharmaceuticals based on its technical analysis. In general, a bottom-up approach, as applied to this company, focuses on Syndax Pharmaceuticals price pattern first instead of the macroeconomic environment surrounding Syndax Pharmaceuticals. By analyzing Syndax Pharmaceuticals's financials, daily price indicators, and related drivers such as dividends, momentum ratios, and various types of growth rates, we attempt to find the most accurate representation of Syndax Pharmaceuticals's intrinsic value. As compared to a bottom-up approach, our top-down model examines the macroeconomic factors that affect the industry/economy before zooming in to Syndax Pharmaceuticals specific price patterns or momentum indicators. Please read more on our technical analysis page.
| 2021 | 2023 | 2024 (projected) | Graham Number | 9.19 | 22.96 | 24.11 | Receivables Turnover | 325.66 | 293.1 | 307.75 |
Syndax Pharmaceuticals June 4, 2024 Technical Indicators
Most technical analysis of Syndax help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for Syndax from various momentum indicators to cycle indicators. When you analyze Syndax charts, please remember that the event formation may indicate an entry point for a short seller, and look at different other indicators across different periods to confirm that a breakdown or reversion is likely to occur.
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | (0.06) | |||
| Market Risk Adjusted Performance | 0.6128 | |||
| Mean Deviation | 2.06 | |||
| Coefficient Of Variation | (917.09) | |||
| Standard Deviation | 2.66 | |||
| Variance | 7.06 | |||
| Information Ratio | (0.12) | |||
| Jensen Alpha | (0.29) | |||
| Total Risk Alpha | (0.41) | |||
| Treynor Ratio | 0.6028 | |||
| Maximum Drawdown | 12.52 | |||
| Value At Risk | (4.65) | |||
| Potential Upside | 3.84 | |||
| Skewness | 0.1657 | |||
| Kurtosis | 0.3792 |
Syndax Pharmaceuticals June 4, 2024 Daily Trend Indicators
Traders often use several different daily volumes and price technical indicators to supplement a more traditional technical analysis when analyzing securities such as Syndax stock. With literally thousands of different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
| Accumulation Distribution | 85,052 | ||
| Daily Balance Of Power | 0.03 | ||
| Rate Of Daily Change | 1.00 | ||
| Day Median Price | 19.83 | ||
| Day Typical Price | 19.65 | ||
| Price Action Indicator | (0.51) |
Additional Tools for Syndax Stock Analysis
When running Syndax Pharmaceuticals' price analysis, check to measure Syndax Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Syndax Pharmaceuticals is operating at the current time. Most of Syndax Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Syndax Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Syndax Pharmaceuticals' price. Additionally, you may evaluate how the addition of Syndax Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.